Single Cell Analysis Market

Single Cell Analysis Market Size, Share & Trends By Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2029

Report Code: BT 4224 Aug, 2024, by marketsandmarkets.com

Updated on : Aug 22, 2024

Single Cell Analysis Market Size, Share & Trends

The single cell analysis market is expected to generate a revenue of USD 6.9 billion in 2029, with a revenue of USD 3.7 billion in 2024 to register a CAGR of 13.6%. Growth of the single-cell analysis market can be attributed to factors such as the rising incidences of cancer and immunological disorders, technological developments in single-cell analysis products, growing focus on advancement of stem cell research, and increasing focus on advancement of biotechnology sector. Additionally, growing research activities for the development of personalized medicine is driving the growth of single-cell analysis market. Also, increasing research and development investments and fundings in pharmaceutical and biotechnology industries for the management of complex diseases is anticipated to promote the single-cell analysis market growth. Moreover, increasing adoption of single-cell sequencing to study cellular heterogeneity is likely to support the growth of the market in coming years. However, high cost of single-cell analysis products may hamper the growth of the market.

Single Cell Analysis Market Trends

Single-Cell Analysis Market

To know about the assumptions considered for the study, Request for Free Sample Report

Attractive Opportunities in the Single Cell Analysis Market

Single-Cell Analysis Market

Single Cell Analysis Market Dynamics

DRIVER: Technological advancements in single-cell analysis products

Players operating in the single-cell analysis market increasingly focus on developing more economical, technologically advanced, and easy-to-use instruments. For instance, in February 2024, 10X Genomics launched the GEM-X technology, next generation of its single-cell technology architecture that will power new assays of its Chromium platform. Chromium GEM-X Single Cell Gene Expression v4 and GEM-X Single Cell Immune Profiling v3 assays are the first two products to use 10X Genomics’s new GEM-X technology architecture. Similarly, in April 2023, Standard BioTools launched a new imaging technology, the Hyperion XTi Imaging System, during the American Association for Cancer Research (AACR) meeting in Orlando.

RESTRAINT: High cost of single-cell analysis products

Cell biology involves extensive research on the development of new therapies, such as stem cell and gene therapies. The instruments, reagents, and other products associated with these research activities are required to be of high quality to obtain accurate results. The use of advanced single-cell analysis techniques is largely dependent on the cost of instruments. Flow cytometers, microfluidic devices, and high-content screening systems equipped with advanced features and functionalities are generally priced at a premium. Advancements in various instruments have led to higher prices than previous-generation instruments due to their expensive development process. For instance, the price of ATTUNE NxT Flow Cytometer Invitrogen offered by Thermo Fisher Scientific Inc. is USD 30,000 each. Similarly, the price of SMARTer ICELL8 cx Single-Cell System offered by Takara Bio Inc. is USD 17,995 each.

OPPORTUNITY: High growth potential of single-cell sequencing

Single-cell sequencing (SCS) helps researchers to understand cellular heterogeneity and transcriptional randomness. Advancements in single-cell sequencing helps to improve detection and analysis of infectious disease outbreaks, antibiotic drug-resistant strains, and microbial diversities in the environment. As single-cell sequencing technology provides detailed information about genetic mutations, companies are focusing on development of instruments and reagents that are suitable for single-cell sequencers. For instance, Illumina, Inc. (US), one of the major players in the single-cell analysis market, offers integrated ultra-low-input and single-cell RNA sequencing workflows (with the SMARTer Ultra Low Input RNA Kit by US-based Clontech Laboratories Inc., combined with the Nextera XT DNA Library Preparation Kit and Illumina sequencing technology) that help in the simplification of the entire process, from library preparation to data analysis and biological interpretation. Considering the high-growth potential of this segment, several advanced SCS instruments are expected to be developed and launched in the market in the coming years.

CHALLENGE: Technical challenges associated with single cell analysis

Despite varied applications and advantages of single-cell analysis, it may sometimes show irregular results as a result of technical limitations associated with the single-cell analysis technique. Some of the technical limitations associated with single-cell analysis include technological biases and amplification errors. Technological biases such as amplification biases and batch effects can affect the results of single-cell analysis. Amplification steps in single-cell analysis may introduce biases, leading to the uneven representation of transcripts and potential distortion of gene expression profiles. Also, Variability between different experimental batches can impact the reproducibility and comparability of single-cell datasets. Therefore, technical challenges associated with single cell analysis are expected to affect the growth of the single-cell analysis market.

Global Single Cell Analysis Market Ecosystem Analysis

The single-cell analysis market ecosystem comprises raw material suppliers, single-cell analysis product manufacturers, and end users such as academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers. Single-cell analysis products manufacturers provide consumables and instruments.

Single-Cell Analysis Market Ecosystem

The human cells segment dominated the single cell analysis industry in 2023.

Based on cell type, the single cell analysis market is segmented into human cells, animal cells, and microbial cells. In 2023, the human cells segment dominated the market owing to growing applications of human stem cells for development of cell-based therapies. Human stem cells are witnessing a significant demand due to the increasing investments in cancer research globally which is expected to support the segment growth. Additionally, human cells are widely used for the diagnosis and treatment of diseases as well as for studying the anatomy and cell functions thus, increasing research activities for cell analysis is anticipated to propel the segment growth in the market. Moreover, growth in stem cell research is likely to propel the segment growth.

The flow cytometry segment dominated the single cell analysis industry in 2023.

Based on the technique, the single-cell analysis market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. In 2023, the flow cytometry segment held the largest market share in the global market owing to growing focus on development of cellular therapies due to increasing rate of cancer and innovations in flow cytometry techniques. Flow cytometry rapidly measures specific characteristics of a large number of individual cells that assist researchers in understanding cell morphologies extensively thus, the utilization of flow cytometry for single-cell analysis to obtain precise results is expected to support the segment growth. Moreover, growing adoption of advanced technologies such as flow cytometry for cell analysis is likely to boost the segment growth.

North America dominated the single cell analysis industry in 2023.

Single-Cell Analysis Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The global single cell analysis market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. North America accounted for the largest share of single-cell analysis market in 2023, followed by Europe and the Asia Pacific. Factors such as increasing development and manufacturing of cell-based therapies, significant investments in R&D activities, and presence of a well-established healthcare sector are responsible for the largest share of North America region in single-cell analysis market.

Key players in the single-cell analysis market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), BD (US), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), 10x Genomics (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), DiaSorin S.p.A. (Italy), Standard BioTools (US), Tecan Trading AG (Switzerland), Sartorius AG (Germany), Corning Incorporated (US), Cytek Biosciences (US), Takara Bio Inc. (Japan), BIOMÉRIEUX (France), Revvity (US), Bio-Techne (US), PacBio (US), Bruker (US), Promega Corporation (US), Oxford Nanopore Technologies plc. (UK), The Menarini Group (Italy), Singleron Biotechnologies (Germany), BICO (Sweden), Fluent BioSciences (US), RareCyte, Inc. (US), Cell Microsystems (US), NanoCellect Biomedical (US), Sphere Fluidics (UK), On-chip Biotechnologies Co., Ltd. Corporation (Japan), and Apogee Flow Systems Ltd. (UK).

Scope of the Single Cell Analysis Industry:

Report Metric

Details

Market Revenue in 2024

$3.7 billion

Projected Revenue by 2029

$6.9 billion

Revenue Rate

Poised to Grow at a CAGR of 13.6%

Market Driver

Technological advancements in single-cell analysis products

Market Opportunity

High growth potential of single-cell sequencing

This report categorizes the single-cell analysis market into the following segments

By Product
  • Consumables
  • Beads
  • Microplates
  • Reagents
  • Assay Kits
  • Immuno Assays
  • Cell-based Assays
  • Other Consumables
  • Instruments
  • Flow Cytometers
  • NGS Systems
  • PCR Instruments
  • Spectrophotometers
  • Cell Counters
  • Microscopes
  • HCS Systems
  • Microarrays
  • Other Instruments
By Cell Type
  • Human Cells
  • Animal Cells
  • Microbial Cells
By Technique
  • Flow cytometry
  • Next-generation sequencing (NGS)
  • Polymerase chain reaction (PCR)
  • Microscopy
  • Mass spectrometry
  • Other techniques
By Application
  • Research Applications
  • Cancer Research
  • Immunology Research
  • Neurology Research
  • Stem Cell Research
  • Other Research Applications
  • Medical Applications
  • Non Invasive Prenatal Diagnosis
  • In Vitro Fertilization
  • Circulating Tumor Cell Detection
By End User
  • Academic & Research Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostic Laboratories
  • Cell Banks & IVF Centers
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East
    • GCC Countries
    • Saudi Arabia (KSA)
    • United Arab Emirates (UAE)
    • Rest of GCC Countries (RoGCC)
    • Rest of Middle East (RoME)
  • Africa

Recent Developments of Single Cell Analysis Industry:

  • In June 2024, Illumina, Inc. launched its latest chemistry, XLEAP-SBS for its NextSeq 1000 and NextSeq 2000 next-generation sequencing (NGS) instruments. XLEAP-SBS chemistry is a faster, higher quality, and more robust sequencing-by-synthesis chemistry that delivers approximately 20% faster turnaround times.
  • In October 2023, Danaher Corporation (Beckman Coulter Life Sciences) partnered with 10x Genomics to expand automation solutions for single cell assay workflows.
  • In February 2023, BD launched BD Rhapsody HT Xpress System, a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing sample integrity, potentially accelerating time to discovery across a wide range of disciplines, including immunology, genetic disease research, and cancer and chronic disease research..
  • In February 2023, Ultima Genomics, Inc. and 10x Genomics collaborated to integrate 10x Genomics Chromium Single Cell Gene Expression solutions with Ultima’s advanced ultra-high throughput sequencing systems.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 45)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 STUDY SCOPE 
           1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
           1.3.2 YEARS CONSIDERED
           1.3.3 INCLUSIONS AND EXCLUSIONS
    1.4 CURRENCY CONSIDERED 
    1.5 UNIT CONSIDERED 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 50)
    2.1 RESEARCH DATA 
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
    2.2 MARKET SIZE ESTIMATION METHODOLOGY 
           2.2.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION, 2023
           2.2.2 INSIGHTS FROM PRIMARY EXPERTS
           2.2.3 TOP-DOWN APPROACH
    2.3 MARKET GROWTH RATE PROJECTIONS 
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RESEARCH LIMITATIONS 
 
3 EXECUTIVE SUMMARY (Page No. - 62)
 
4 PREMIUM INSIGHTS (Page No. - 66)
    4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SINGLE-CELL ANALYSIS MARKET 
    4.2 SINGLE-CELL ANALYSIS MARKET IN NORTH AMERICA, BY CELL TYPE AND COUNTRY 
    4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT 
    4.4 SINGLE-CELL ANALYSIS MARKET, BY END USER 
    4.5 SINGLE-CELL ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
 
5 MARKET OVERVIEW (Page No. - 69)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Technological advancements in single-cell analysis products
                    5.2.1.2 Rising prevalence of cancer
                    5.2.1.3 Increasing R&D in pharmaceutical and biotechnology industries
                    5.2.1.4 Growth in stem cell research
                    5.2.1.5 Growing focus on personalized medicine
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of single-cell analysis products
           5.2.3 OPPORTUNITIES
                    5.2.3.1 High growth potential of single-cell sequencing
                    5.2.3.2 Integration of microfluidics in single-cell analysis
                    5.2.3.3 Rising potential in emerging Asian markets
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of standardization in protocols and quality control procedures
                    5.2.4.2 Technical limitations of single-cell analysis
                    5.2.4.3 Mounting ethical and privacy concerns
    5.3 TECHNOLOGY ANALYSIS 
           5.3.1 KEY TECHNOLOGIES
                    5.3.1.1 Flow cytometry
                    5.3.1.2 Next-generation sequencing
                    5.3.1.3 Polymerase chain reaction
                    5.3.1.4 Microscopy
                    5.3.1.5 Mass spectrometry
           5.3.2 COMPLEMENTARY TECHNOLOGIES
                    5.3.2.1 Bioinformatics tools and computational analysis
                    5.3.2.2 Multi-omics integration
           5.3.3 ADJACENT TECHNOLOGIES
                    5.3.3.1 Nanotechnology
                    5.3.3.2 Artificial intelligence and machine learning
    5.4 SUPPLY CHAIN ANALYSIS 
    5.5 VALUE CHAIN ANALYSIS 
    5.6 PRICING ANALYSIS 
    5.7 ECOSYSTEM ANALYSIS 
    5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 
    5.9 PATENT ANALYSIS 
           5.9.1 METHODOLOGY
           5.9.2 PATENTS APPLIED AND GRANTED, 2014–2024
    5.10 KEY CONFERENCES AND EVENTS, 2024–2025 
    5.11 REGULATORY LANDSCAPE 
           5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.11.2 REGULATIONS
    5.12 PORTER’S FIVE FORCES ANALYSIS 
           5.12.1 THREAT OF NEW ENTRANTS
           5.12.2 THREAT OF SUBSTITUTES
           5.12.3 BARGAINING POWER OF SUPPLIERS
           5.12.4 BARGAINING POWER OF BUYERS
           5.12.5 INTENSITY OF COMPETITIVE RIVALRY
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS
           5.13.3 BUYING CRITERIA
    5.14 INVESTMENT AND FUNDING SCENARIO 
    5.15 TRADE ANALYSIS 
           5.15.1 IMPORT DATA (HS CODE 9027)
           5.15.2 EXPORT DATA (HS CODE 9027)
    5.16 IMPACT OF GENERATIVE AI ON SINGLE-CELL ANALYSIS MARKET 
 
6 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT (Page No. - 113)
    6.1 INTRODUCTION 
    6.2 CONSUMABLES 
           6.2.1 BEADS
                    6.2.1.1 Increasing use in research and genetic exploration to drive market
           6.2.2 MICROPLATES
                    6.2.2.1 Rising frequency of product launches to boost market
           6.2.3 REAGENTS
                    6.2.3.1 Advancements in single-cell genomics to increase demand
           6.2.4 ASSAY KITS
                    6.2.4.1 Immunoassays
                               6.2.4.1.1 Growth in geriatric population to fuel demand
                    6.2.4.2 Cell-based assays
                               6.2.4.2.1 Increasing use in pharma and biopharma companies to drive market
           6.2.5 OTHER CONSUMABLES
    6.3 INSTRUMENTS 
           6.3.1 FLOW CYTOMETERS
                    6.3.1.1 Technological advancements to drive demand
           6.3.2 NGS SYSTEMS
                    6.3.2.1 Increased affordability to support segment growth
           6.3.3 PCR INSTRUMENTS
                    6.3.3.1 Rising use for DNA and mRNA amplification to boost market
           6.3.4 SPECTROPHOTOMETERS
                    6.3.4.1 Technological advancements to boost market
           6.3.5 CELL COUNTERS
                    6.3.5.1 Rising demand for automated cell counters to fuel market
           6.3.6 MICROSCOPES
                    6.3.6.1 Increasing use in cell-based research to drive market
           6.3.7 HCS SYSTEMS
                    6.3.7.1 Growing need for multi-parametric cell analysis to drive adoption
           6.3.8 MICROARRAYS
                    6.3.8.1 Increasing development of targeted therapies to support market
           6.3.9 OTHER INSTRUMENTS
 
7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE (Page No. - 167)
    7.1 INTRODUCTION 
    7.2 HUMAN CELLS 
           7.2.1 GROWING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND
    7.3 ANIMAL CELLS 
           7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET
    7.4 MICROBIAL CELLS 
           7.4.1 RISING GOVERNMENT SUPPORT TO COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET
 
8 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE (Page No. - 178)
    8.1 INTRODUCTION 
    8.2 FLOW CYTOMETRY 
           8.2.1 INCREASING USE TO IDENTIFY CANCEROUS CELLS TO DRIVE MARKET
    8.3 NEXT-GENERATION SEQUENCING 
           8.3.1 WIDE ADOPTION IN DRUG DISCOVERY TO DRIVE MARKET
    8.4 POLYMERASE CHAIN REACTION 
           8.4.1 INCREASING APPLICATIONS OF DIGITAL PCR TO SUPPORT MARKET
    8.5 MICROSCOPY 
           8.5.1 FOCUS ON DEVELOPMENT OF ADVANCED IMAGING SYSTEMS TO PROPEL MARKET
    8.6 MASS SPECTROMETRY 
           8.6.1 LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET
    8.7 OTHER TECHNIQUES 
 
9 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION (Page No. - 199)
    9.1 INTRODUCTION 
    9.2 RESEARCH APPLICATIONS 
           9.2.1 CANCER RESEARCH
                    9.2.1.1 Rising prevalence of cancer to drive market
           9.2.2 IMMUNOLOGY RESEARCH
                    9.2.2.1 High incidence of immunological disorders to propel market
           9.2.3 NEUROLOGY RESEARCH
                    9.2.3.1 Increasing incidence of neurological disorders to boost market
           9.2.4 STEM CELL RESEARCH
                    9.2.4.1 Rising investments in stem cell research to drive market
           9.2.5 OTHER RESEARCH APPLICATIONS
    9.3 MEDICAL APPLICATIONS 
           9.3.1 NON-INVASIVE PRENATAL DIAGNOSIS
                    9.3.1.1 Increasing prevalence of genetic diseases to drive demand
           9.3.2 IN VITRO FERTILIZATION
                    9.3.2.1 Growing demand for IVF procedures to support market
           9.3.3 CIRCULATING TUMOR CELL DETECTION
                    9.3.3.1 Rising prevalence of cancer to contribute to segment growth
 
10 SINGLE-CELL ANALYSIS MARKET, BY END USER (Page No. - 233)
     10.1 INTRODUCTION 
     10.2 ACADEMIC & RESEARCH LABORATORIES 
             10.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
     10.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 
             10.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO BOOST MARKET
     10.4 HOSPITALS & DIAGNOSTIC LABORATORIES 
             10.4.1 HIGH PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES TO DRIVE DEMAND
     10.5 CELL BANKS & IVF CENTERS 
             10.5.1 RISING DEMAND FOR PERSONALIZED AND REGENERATIVE MEDICINE TO PROPEL MARKET
 
11 SINGLE-CELL ANALYSIS MARKET, BY REGION (Page No. - 249)
     11.1 INTRODUCTION 
     11.2 NORTH AMERICA 
             11.2.1 US
                        11.2.1.1 Increasing R&D investments and funding to drive market
             11.2.2 CANADA
                        11.2.2.1 High prevalence of hemophilia to propel market
     11.3 EUROPE 
             11.3.1 GERMANY
                        11.3.1.1 Growing awareness of advanced cell therapies to support market
             11.3.2 UK
                        11.3.2.1 Growing adoption of single-cell analysis products to drive demand
             11.3.3 FRANCE
                        11.3.3.1 Growing government funding for R&D to propel market
             11.3.4 ITALY
                        11.3.4.1 Focus on cell biology research to drive market
             11.3.5 SPAIN
                        11.3.5.1 Increasing number of biotechnology companies to drive demand
             11.3.6 REST OF EUROPE
     11.4 ASIA PACIFIC 
             11.4.1 CHINA
                        11.4.1.1 Increasing R&D expenditure to support market
             11.4.2 JAPAN
                        11.4.2.1 Increasing geriatric population to fuel demand
             11.4.3 INDIA
                        11.4.3.1 Growing focus on development of cell-based therapies to boost market
             11.4.4 SOUTH KOREA
                        11.4.4.1 Increasing number of strategic alliances to boost market
             11.4.5 AUSTRALIA
                        11.4.5.1 Rising number of life science companies to boost demand
             11.4.6 REST OF ASIA PACIFIC
     11.5 LATIN AMERICA 
             11.5.1 BRAZIL
                        11.5.1.1 Rising focus on biotechnology industry to bolster market
             11.5.2 MEXICO
                        11.5.2.1 Government support for biopharmaceutical production to drive market
             11.5.3 REST OF LATIN AMERICA
     11.6 MIDDLE EAST 
             11.6.1 GCC
                        11.6.1.1 Focus on advancement of local biopharmaceutical industry to drive market
                        11.6.1.2 Saudi Arabia
                                     11.6.1.2.1 Increasing healthcare expenditure to drive market
                        11.6.1.3 United Arab Emirates
                                     11.6.1.3.1 Advancements in biopharmaceutical sector to drive demand
                        11.6.1.4 Rest of GCC
             11.6.2 REST OF MIDDLE EAST
     11.7 AFRICA 
             11.7.1 GROWING FUNDING FOR DEVELOPMENT AND PRODUCTION OF BIOPHARMACEUTICALS TO DRIVE MARKET
 
12 COMPETITIVE LANDSCAPE (Page No. - 367)
     12.1 OVERVIEW 
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023 
     12.3 REVENUE ANALYSIS, 2021–2023 
     12.4 MARKET SHARE ANALYSIS, 2023 
     12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
             12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        12.5.5.1 Company footprint
                        12.5.5.2 Product footprint
                        12.5.5.3 Region footprint
                        12.5.5.4 Technique footprint
                        12.5.5.5 Application footprint
     12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 RESPONSIVE COMPANIES
             12.6.3 DYNAMIC COMPANIES
             12.6.4 STARTING BLOCKS
             12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
                        12.6.5.1 Detailed list of key startups/SMEs
                        12.6.5.2 Competitive benchmarking of key startups/SMEs
     12.7 COMPANY VALUATION AND FINANCIAL METRICS 
     12.8 BRAND/PRODUCT COMPARISON 
     12.9 COMPETITIVE SCENARIO AND TRENDS 
             12.9.1 PRODUCT LAUNCHES & APPROVALS
             12.9.2 DEALS
             12.9.3 EXPANSIONS
 
13 COMPANY PROFILES (Page No. - 389)
     13.1 INTRODUCTION 
     13.2 KEY PLAYERS 
             13.2.1 BD
                        13.2.1.1 Business overview
                        13.2.1.2 Products offered
                        13.2.1.3 Recent developments
                                     13.2.1.3.1 Product launches & approvals
                                     13.2.1.3.2 Deals
                        13.2.1.4 MnM view
                                     13.2.1.4.1 Key strengths
                                     13.2.1.4.2 Strategic choices
                                     13.2.1.4.3 Weaknesses and competitive threats
             13.2.2 THERMO FISHER SCIENTIFIC INC.
                        13.2.2.1 Business overview
                        13.2.2.2 Products offered
                        13.2.2.3 Recent developments
                                     13.2.2.3.1 Product launches & approvals
                                     13.2.2.3.2 Deals
                        13.2.2.4 MnM view
                                     13.2.2.4.1 Key strengths
                                     13.2.2.4.2 Strategic choices
                                     13.2.2.4.3 Weaknesses and competitive threats
             13.2.3 DANAHER CORPORATION
                        13.2.3.1 Business overview
                        13.2.3.2 Products offered
                        13.2.3.3 Recent developments
                                     13.2.3.3.1 Deals
                        13.2.3.4 MnM view
                                     13.2.3.4.1 Key strengths
                                     13.2.3.4.2 Strategic choices
                                     13.2.3.4.3 Weaknesses and competitive threats
             13.2.4 10X GENOMICS
                        13.2.4.1 Business overview
                        13.2.4.2 Products offered
                        13.2.4.3 Recent developments
                                     13.2.4.3.1 Product launches & approvals
                                     13.2.4.3.2 Deals
             13.2.5 MERCK KGAA
                        13.2.5.1 Business overview
                        13.2.5.2 Products offered
                        13.2.5.3 Recent developments
                                     13.2.5.3.1 Deals
             13.2.6 AGILENT TECHNOLOGIES, INC.
                        13.2.6.1 Business overview
                        13.2.6.2 Products offered
                        13.2.6.3 Recent developments
                                     13.2.6.3.1 Product launches & approvals
                                     13.2.6.3.2 Deals
             13.2.7 QIAGEN
                        13.2.7.1 Business overview
                        13.2.7.2 Products offered
                        13.2.7.3 Recent developments
                                     13.2.7.3.1 Deals
             13.2.8 ILLUMINA, INC.
                        13.2.8.1 Business overview
                        13.2.8.2 Products offered
                        13.2.8.3 Recent developments
                                     13.2.8.3.1 Product launches & approvals
                                     13.2.8.3.2 Deals
             13.2.9 BIO-RAD LABORATORIES, INC.
                        13.2.9.1 Business overview
                        13.2.9.2 Products offered
                        13.2.9.3 Recent developments
                                     13.2.9.3.1 Product launches & approvals
             13.2.10 DIASORIN S.P.A.
                        13.2.10.1 Business overview
                        13.2.10.2 Products offered
                        13.2.10.3 Recent developments
                                     13.2.10.3.1 Deals
             13.2.11 STANDARD BIOTOOLS
                        13.2.11.1 Business overview
                        13.2.11.2 Product offered
                        13.2.11.3 Recent developments
                                     13.2.11.3.1 Product launches & approvals
                                     13.2.11.3.2 Deals
             13.2.12 TECAN TRADING AG
                        13.2.12.1 Business overview
                        13.2.12.2 Products offered
             13.2.13 SARTORIUS AG
                        13.2.13.1 Business overview
                        13.2.13.2 Products offered
                        13.2.13.3 Recent developments
                                     13.2.13.3.1 Expansions
             13.2.14 CORNING INCORPORATED
                        13.2.14.1 Business overview
                        13.2.14.2 Products offered
             13.2.15 CYTEK BIOSCIENCES
                        13.2.15.1 Business overview
                        13.2.15.2 Products offered
                        13.2.15.3 Recent developments
                                     13.2.15.3.1 Expansions
             13.2.16 TAKARA BIO INC.
                        13.2.16.1 Business overview
                        13.2.16.2 Products offered
             13.2.17 BIOMÉRIEUX
                        13.2.17.1 Business overview
                        13.2.17.2 Products offered
                        13.2.17.3 Recent developments
                                     13.2.17.3.1 Deals
             13.2.18 REVVITY
                        13.2.18.1 Business overview
                        13.2.18.2 Products offered
                        13.2.18.3 Recent developments
                                     13.2.18.3.1 Deals
             13.2.19 BIO-TECHNE
                        13.2.19.1 Business overview
                        13.2.19.2 Products offered
                        13.2.19.3 Recent developments
                                     13.2.19.3.1 Deals
             13.2.20 PACBIO
                        13.2.20.1 Business overview
                        13.2.20.2 Products offered
                        13.2.20.3 Recent developments
                                     13.2.20.3.1 Product launches & approvals
             13.2.21 BRUKER
                        13.2.21.1 Business overview
                        13.2.21.2 Products offered
                        13.2.21.3 Recent developments
                                     13.2.21.3.1 Product launches & approvals
             13.2.22 PROMEGA CORPORATION
                        13.2.22.1 Business overview
                        13.2.22.2 Products offered
             13.2.23 OXFORD NANOPORE TECHNOLOGIES PLC
                        13.2.23.1 Business overview
                        13.2.23.2 Products offered
     13.3 OTHER PLAYERS 
             13.3.1 SINGLERON BIOTECHNOLOGIES
             13.3.2 CELL MICROSYSTEMS
             13.3.3 NANOCELLECT BIOMEDICAL
             13.3.4 RARECYTE, INC.
             13.3.5 BICO
             13.3.6 MENARINI GROUP
 
14 DISCUSSION GUIDE (Page No. - 474)
     14.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.2 CUSTOMIZATION OPTIONS 
     14.3 RELATED REPORTS 
     14.4 AUTHOR DETAILS 
 
 
LIST OF TABLES (699 TABLES)
 
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS
TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND PRODUCT LAUNCHES
TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
TABLE 5 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)
TABLE 6 ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH, 2019–2025
TABLE 7 APPLICATIONS OF MICROSCOPIC TECHNIQUES IN SINGLE-CELL ANALYSIS
TABLE 8 TYPES OF BIOINFORMATICS TOOLS
TABLE 9 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021–2023
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
TABLE 11 SINGLE-CELL ANALYSIS MARKET: RAW MATERIAL VENDORS
TABLE 12 SINGLE-CELL ANALYSIS MARKET: PRODUCT VENDORS
TABLE 13 SINGLE-CELL ANALYSIS MARKET: END USERS
TABLE 14 SINGLE-CELL ANALYSIS MARKET: REGULATORY BODIES
TABLE 15 PATENTS FILED, 2014–2024
TABLE 16 INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024
TABLE 17 SINGLE-CELL ANALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2024–2025
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 SINGLE-CELL ANALYSIS MARKET: REGULATORY GUIDELINES
TABLE 23 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 24 BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS, BY END USER
TABLE 25 IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019–2023 (USD THOUSAND)
TABLE 26 IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019–2023 (TONS)
TABLE 27 EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019–2023 (USD THOUSAND)
TABLE 28 EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2019–2023 (TONS)
TABLE 29 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 30 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 31 SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 32 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 33 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY REGION, 2022–2029 (USD MILLION)
TABLE 39 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 GCC: SINGLE-CELL ANALYSIS MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROPLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 53 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 GCC: SINGLE-CELL ANALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 60 SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY REGION, 2022–2029 (USD MILLION)
TABLE 61 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY REGION, 2022–2029 (USD MILLION)
TABLE 68 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
TABLE 75 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 MIDDLE EAST: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 GCC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 81 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 89 SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 92 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 EUROPE: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99 ASIA PACIFIC: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 LATIN AMERICA: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 MIDDLE EAST: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 GCC: SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 104 NORTH AMERICA: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 EUROPE: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 ASIA PACIFIC: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107 LATIN AMERICA: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 MIDDLE EAST: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 GCC: SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 111 NORTH AMERICA: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 EUROPE: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 ASIA PACIFIC: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 LATIN AMERICA: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 MIDDLE EAST: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 GCC: SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 118 NORTH AMERICA: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 EUROPE: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 LATIN AMERICA: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 MIDDLE EAST: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 GCC: SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 125 NORTH AMERICA: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 EUROPE: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 ASIA PACIFIC: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 LATIN AMERICA: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 MIDDLE EAST: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130 GCC: SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 132 NORTH AMERICA: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 EUROPE: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 LATIN AMERICA: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 MIDDLE EAST: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 GCC: SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 139 NORTH AMERICA: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 EUROPE: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 ASIA PACIFIC: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 LATIN AMERICA: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 MIDDLE EAST: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 GCC: SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 146 NORTH AMERICA: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 EUROPE: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 ASIA PACIFIC: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 149 LATIN AMERICA: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 MIDDLE EAST: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 GCC: SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 153 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 155 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 156 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 157 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 160 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 161 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 163 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 164 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 GCC: SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 168 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 172 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 GCC: SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 175 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 177 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 182 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022–2029 (USD MILLION)
TABLE 183 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 186 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 GCC: SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
TABLE 190 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 193 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2022–2029 (USD MILLION)
TABLE 197 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 200 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 GCC: SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2022–2029 (USD MILLION)
TABLE 204 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 206 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 207 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 GCC: SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2022–2029 (USD MILLION)
TABLE 211 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 213 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 214 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 215 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 GCC: SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION)
TABLE 218 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 220 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 221 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 222 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 225 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 227 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 228 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 229 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 234 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 236 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239 GCC: SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 241 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 244 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 245 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 GCC: SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 248 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 250 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 251 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 252 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 GCC: SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 255 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 257 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 258 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 259 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 260 GCC: SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 262 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 264 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 265 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 266 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 267 GCC: SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 270 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 271 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 272 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 273 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 275 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 276 SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 277 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 278 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 279 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 280 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 281 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 282 GCC: SINGLE-CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 283 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2022–2029 (USD MILLION)
TABLE 284 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 285 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 286 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 287 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 288 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 289 GCC: SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 290 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2022–2029 (USD MILLION)
TABLE 291 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 292 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 293 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 294 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 295 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 296 GCC: SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 297 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 298 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 299 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 300 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 301 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 302 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 303 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 304 GCC: SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 305 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 306 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 307 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 308 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 309 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 310 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 311 GCC: SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 312 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 313 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 314 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 315 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 316 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 317 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 318 GCC: SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 319 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 320 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 321 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 322 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 323 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 324 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 325 GCC: SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 326 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 327 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 328 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 329 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 330 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 331 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 332 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 333 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 334 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 335 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 336 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 338 US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 339 US: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 340 US: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 341 US: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 342 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 343 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 344 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 345 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 346 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 347 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 348 CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 349 CANADA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 350 CANADA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 351 CANADA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 352 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 353 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 354 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 355 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 356 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 357 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 358 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 359 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 360 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 361 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 362 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 363 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 364 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 365 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 366 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 367 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 368 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 369 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 370 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 371 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 372 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 373 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 374 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 375 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 376 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 379 UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 380 UK: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 381 UK: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 382 UK: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 383 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 384 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 385 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 386 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 387 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 388 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 389 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 390 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 391 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 392 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 393 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 394 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 395 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 396 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 397 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 399 ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 400 ITALY: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 401 ITALY: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 402 ITALY: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 403 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 404 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 405 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 406 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 407 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 408 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 409 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 410 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 411 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 412 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 413 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 414 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 415 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 416 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 417 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 418 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 419 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 420 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 421 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 422 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 423 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 424 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 425 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 426 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 428 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 429 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 430 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 431 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 432 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 433 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 434 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 435 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 436 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 437 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 438 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 439 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 440 CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 441 CHINA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 442 CHINA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 443 CHINA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 444 CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 445 CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 446 CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 447 CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 448 CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 449 CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 450 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 451 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 452 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 453 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 454 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 455 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 456 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 457 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 458 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 459 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 460 INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 461 INDIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 462 INDIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 463 INDIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 464 INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 465 INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 466 INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 467 INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 468 INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 469 INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 470 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 471 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 472 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 473 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 474 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 475 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 476 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 477 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 478 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 479 SOUTH KOREA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 480 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 481 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 482 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 483 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 484 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 485 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 486 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 487 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 488 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 489 AUSTRALIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 490 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 491 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 492 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 493 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 494 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 495 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 496 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 497 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 498 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 499 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 500 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 501 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 502 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 503 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 504 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 505 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 506 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 507 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 508 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 509 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 510 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 511 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 512 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 513 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 514 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 515 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 516 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 517 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 518 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 519 BRAZIL: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 520 BRAZIL: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 521 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 522 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE,  2022–2029 (USD MILLION)
TABLE 523 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 524 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 525 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 526 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 527 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 528 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 529 MEXICO: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 530 MEXICO: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 531 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 532 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 533 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 534 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 535 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 536 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 537 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 538 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 539 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 540 REST OF LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 541 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 542 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 543 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 544 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 545 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 546 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 547 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 548 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 549 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 550 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 551 MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 552 GCC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 553 GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 554 GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 555 GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 556 GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 557 GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 558 GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 559 GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 560 GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 561 GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 562 GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 563 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 564 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 565 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 566 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 567 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 568 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 569 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 570 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 571 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 572 SAUDI ARABIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 573 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 574 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 575 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 576 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 577 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 578 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 579 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 580 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 581 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 582 UNITED ARAB EMIRATES: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 583 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 584 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 585 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 586 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 587 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 588 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 589 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 590 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 591 REST OF GCC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 592 REST OF GCC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 593 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 594 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 595 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 596 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 597 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 598 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 599 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 600 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 601 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 602 REST OF MIDDLE EAST: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 603 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 604 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 605 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR ASSAY KITS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 606 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 607 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 608 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 609 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 610 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 611 AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 612 AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 613 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 614 SINGLE-CELL ANALYSIS MARKET: DEGREE OF COMPETITION
TABLE 615 SINGLE-CELL ANALYSIS MARKET: PRODUCT FOOTPRINT
TABLE 616 SINGLE-CELL ANALYSIS MARKET: REGION FOOTPRINT
TABLE 617 SINGLE-CELL ANALYSIS MARKET: TECHNIQUE FOOTPRINT
TABLE 618 SINGLE-CELL ANALYSIS MARKET: APPLICATION FOOTPRINT
TABLE 619 SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 620 SINGLE-CELL ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 621 SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2024
TABLE 622 SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2021–JULY 2024
TABLE 623 SINGLE-CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2021–JULY 2024
TABLE 624 BD: COMPANY OVERVIEW
TABLE 625 BD: PRODUCTS OFFERED
TABLE 626 BD: PRODUCT LAUNCHES & APPROVALS
TABLE 627 BD: DEALS
TABLE 628 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 629 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 630 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 631 THERMO FISHER SCIENTIFIC INC.: DEALS
TABLE 632 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 633 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 634 DANAHER CORPORATION: DEALS
TABLE 635 10X GENOMICS: COMPANY OVERVIEW
TABLE 636 10X GENOMICS: PRODUCTS OFFERED
TABLE 637 10X GENOMICS: PRODUCT LAUNCHES & APPROVALS
TABLE 638 10X GENOMICS: DEALS
TABLE 639 MERCK KGAA: COMPANY OVERVIEW
TABLE 640 MERCK KGAA: PRODUCTS OFFERED
TABLE 641 MERCK KGAA: DEALS
TABLE 642 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 643 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 644 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 645 AGILENT TECHNOLOGIES, INC.: DEALS
TABLE 646 QIAGEN: COMPANY OVERVIEW
TABLE 647 QIAGEN: PRODUCTS OFFERED
TABLE 648 QIAGEN: DEALS
TABLE 649 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 650 ILLUMINA, INC.: PRODUCTS OFFERED
TABLE 651 ILLUMINA, INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 652 ILLUMINA, INC.: DEALS
TABLE 653 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 654 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 655 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 656 DIASORIN S.P.A.: COMPANY OVERVIEW
TABLE 657 DIASORIN S.P.A.: PRODUCTS OFFERED
TABLE 658 DIASORIN S.P.A.: DEALS
TABLE 659 STANDARD BIOTOOLS: COMPANY OVERVIEW
TABLE 660 STANDARD BIOTOOLS: PRODUCTS OFFERED
TABLE 661 STANDARD BIOTOOLS: PRODUCT LAUNCHES & APPROVALS
TABLE 662 STANDARD BIOTOOLS: DEALS
TABLE 663 TECAN TRADING AG: COMPANY OVERVIEW
TABLE 664 TECAN TRADING AG: PRODUCTS OFFERED
TABLE 665 SARTORIUS AG: COMPANY OVERVIEW
TABLE 666 SARTORIUS AG: PRODUCTS OFFERED
TABLE 667 SARTORIUS AG: EXPANSIONS
TABLE 668 CORNING INCORPORATED: COMPANY OVERVIEW
TABLE 669 CORNING INCORPORATED: PRODUCTS OFFERED
TABLE 670 CYTEK BIOSCIENCES: COMPANY OVERVIEW
TABLE 671 CYTEK BIOSCIENCES: PRODUCTS OFFERED
TABLE 672 CYTEK BIOSCIENCES: EXPANSIONS
TABLE 673 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 674 TAKARA BIO INC.: PRODUCTS OFFERED
TABLE 675 BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 676 BIOMÉRIEUX: PRODUCTS OFFERED
TABLE 677 BIOMÉRIEUX: DEALS
TABLE 678 REVVITY: COMPANY OVERVIEW
TABLE 679 REVVITY: PRODUCTS OFFERED
TABLE 680 REVVITY: DEALS
TABLE 681 BIO-TECHNE: COMPANY OVERVIEW
TABLE 682 BIO-TECHNE: PRODUCTS OFFERED
TABLE 683 BIO-TECHNE: DEALS
TABLE 684 PACBIO: COMPANY OVERVIEW
TABLE 685 PACBIO: PRODUCTS OFFERED
TABLE 686 PACBIO: PRODUCT LAUNCHES & APPROVALS
TABLE 687 BRUKER: COMPANY OVERVIEW
TABLE 688 BRUKER: PRODUCTS OFFERED
TABLE 689 BRUKER: PRODUCT LAUNCHES & APPROVALS
TABLE 690 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 691 PROMEGA CORPORATION: PRODUCTS OFFERED
TABLE 692 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
TABLE 693 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS OFFERED
TABLE 694 SINGLERON BIOTECHNOLOGIES: BUSINESS OVERVIEW
TABLE 695 CELL MICROSYSTEMS: BUSINESS OVERVIEW
TABLE 696 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW
TABLE 697 RARECYTE, INC.: BUSINESS OVERVIEW
TABLE 698 BICO: BUSINESS OVERVIEW
TABLE 699 MENARINI GROUP: BUSINESS OVERVIEW
 
 
LIST OF FIGURES (65 FIGURES)
 
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE-CELL ANALYSIS MARKET
FIGURE 3 SINGLE-CELL ANALYSIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 5 ILLUSTRATIVE EXAMPLE OF BD COMPANY: REVENUE ANALYSIS, 2023
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 8 SINGLE-CELL ANALYSIS MARKET: CAGR PROJECTIONS
FIGURE 9 DATA TRIANGULATION METHODOLOGY
FIGURE 10 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 11 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 12 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 15 GEOGRAPHIC SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET
FIGURE 16 GROWTH IN STEM CELL RESEARCH TO DRIVE MARKET
FIGURE 17 HUMAN CELLS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2023
FIGURE 18 CONSUMABLES SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2023
FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 21 SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 AGE-STANDARDIZED RATE (WORLD) PER 1,00,000 CANCER INCIDENCES IN BOTH SEXES, 2022
FIGURE 23 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2014–2028
FIGURE 24 SHARE OF PERSONALIZED MEDICINE IN FDA'S NEW DRUG APPROVALS FOR LAST NINE YEARS
FIGURE 25 SINGLE-CELL ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 26 SINGLE-CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS
FIGURE 27 SINGLE-CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS
FIGURE 28 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 29 PATENT APPLICATIONS IN SINGLE-CELL ANALYSIS MARKET, JANUARY 2014–JUNE 2024
FIGURE 30 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS
FIGURE 32 KEY BUYING CRITERIA FOR END USERS
FIGURE 33 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETERS, 2022–2029 (THOUSAND UNITS)
FIGURE 34 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
FIGURE 35 NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025
FIGURE 36 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET, 2021–2023
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
FIGURE 39 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 40 SINGLE-CELL ANALYSIS MARKET: COMPANY FOOTPRINT
FIGURE 41 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023
FIGURE 42 EV/EBITDA OF KEY VENDORS
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 44 SINGLE-CELL ANALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 45 BD: COMPANY SNAPSHOT
FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 48 10X GENOMICS: COMPANY SNAPSHOT
FIGURE 49 MERCK KGAA: COMPANY SNAPSHOT
FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
FIGURE 51 QIAGEN: COMPANY SNAPSHOT
FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 54 DIASORIN S.P.A.: COMPANY SNAPSHOT
FIGURE 55 STANDARD BIOTOOLS: COMPANY SNAPSHOT
FIGURE 56 TECAN TRADING AG: COMPANY SNAPSHOT
FIGURE 57 SARTORIUS AG: COMPANY SNAPSHOT
FIGURE 58 CORNING INCORPORATED: COMPANY SNAPSHOT
FIGURE 59 CYTEK BIOSCIENCES: COMPANY SNAPSHOT
FIGURE 60 TAKARA BIO INC.: COMPANY SNAPSHOT
FIGURE 61 BIOMÉRIEUX: COMPANY SNAPSHOT
FIGURE 62 REVVITY: COMPANY SNAPSHOT
FIGURE 63 BIO-TECHNE: COMPANY SNAPSHOT
FIGURE 64 PACBIO: COMPANY SNAPSHOT
FIGURE 65 BRUKER: COMPANY SNAPSHOT

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-cell analysis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), International Clinical Cytometry Society (ICCS), International Society for Advancement of Cytometry (ISAC), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), and Society for Laboratory Automation and Screening (SLAS), Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global single-cell analysis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks, and IVF centers, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Single-Cell Analysis Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the single-cell analysis business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Single-Cell Analysis Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Single-Cell Analysis Market Size, and Share

Data Triangulation

After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Single-cell analysis is a method for examining individual cells across various parameters, particularly beneficial when dealing with diverse cell populations. This approach focuses on studying a single cell isolated from tissues in a multicellular organism. Technologies including flow cytometry and microfluidics are used for single-cell analysis purpose. Such analysis facilitates the exploration of variations between cells within a population. Currently, single-cell analysis finds extensive applications in cancer research, immunology, stem cell research, and neurobiology.

Stakeholders

  • Single-cell analysis product manufacturers, vendors, and distributors
  • Academic and research laboratories
  • Pharmaceutical and biopharmaceutical companies
  • Venture capitalists and investors
  • Government organizations
  • Private research firms
  • Cell Banks & IVF centers
  • Hospitals & diagnostic centers

Report Objectives

  • To define, describe, segment, and forecast the single-cell analysis market by product, cell type, technique, application, end user, and region
  • To provide detailed information about the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall single-cell analysis market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments concerning six main regions: North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa
  • To strategically profile the key players in the global single-cell analysis market and comprehensively analyze their core competencies2 and market rankings
  • To track and analyze competitive developments in the single-cell analysis market, such as product launches, acquisitions, collaborations, expansions, and partnerships
  • To benchmark players within the single-cell analysis market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business excellence and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.
Company Information
  • Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
  • A further breakdown of the Rest of Europe  single-cell analysis market into countries
  • A further breakdown of the Rest of Asia Pacific single-cell analysis market into countries
  • A further breakdown of the Rest of Latin American single-cell analysis market into countries
  • A further breakdown of the Rest of Middle East single-cell analysis market into countries
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 4224
Published ON
Aug, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Single Cell Analysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback